Photo from wikipedia
Highlights • 5-year survival for stage I uterine carcinosarcoma without adjuvant therapy is 43%.• Nationally 40% of stage I uterine carcinosarcoma do not receive adjuvant therapy.• Adjuvant chemotherapy alone improved… Click to show full abstract
Highlights • 5-year survival for stage I uterine carcinosarcoma without adjuvant therapy is 43%.• Nationally 40% of stage I uterine carcinosarcoma do not receive adjuvant therapy.• Adjuvant chemotherapy alone improved OS and CSS in stage I uterine carcinosarcoma.
Keywords:
survival;
adjuvant treatment;
uterine carcinosarcoma;
stage uterine;
patterns adjuvant
Journal Title: Gynecologic Oncology Reports
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Gynecologic Oncology Reports
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!